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Abstract: Seven-week-old male Lewis rats received a single intraperitoneal injection of N-ethyl-N-nitrosourea (ENU) (100, 200, 
400 or 600 mg/kg), and retinal damage was evaluated 7 days after the treatment. Sequential morphological features of the retina and 
retinal DNA damage, as determined by a TUNEL assay and phospho-histone H2A.X (γ-H2AX), were analyzed 3, 6, 12, 24 and 72 
hr, 7 days, and/or 30 days after 400 mg/kg ENU treatment. Activation of the nuclear enzyme poly (ADP-ribose) polymerase (PARP) 
was analyzed immunohistochemically by poly (ADP-ribose) (PAR) expression in response to DNA damage of the retina. All rats that 
received ≥ 400 mg/kg of ENU developed retinal degeneration characterized by the loss of photoreceptor cells in both the central and 
peripheral retina within 7 days. In the 400 mg/kg ENU-treated rats, TUNEL-positive signals were only located in the photoreceptor 
cells and peaked 24 hr after ENU treatment. The γ-H2AX signals in inner retinal cells appeared at 24 hr and peaked at 72 hr after ENU 
treatment, and the PAR signals selectively located in the photoreceptor cell nuclei appeared at 12 hr and peaked at 24 hr after ENU 
treatment. However, degeneration was restricted to photoreceptor cells, and no degenerative changes in inner retinal cells were seen 
at any time points. Retinal thickness and the photoreceptor cell ratio in the central and peripheral retina were significantly decreased, 
and the retinal damage ratio was significantly increased 7 days after ENU treatment. In conclusion, ENU induced retinal degeneration 
in adult rats that was characterized by photoreceptor cell apoptosis through PARP activity. (DOI: 10.1293/tox.25.27; J Toxicol Pathol 
2012; 25: 27–35)
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Introduction
N-Ethyl-N-nitrosourea (ENU) is an alkylating agent 
that is particularly effective in inducing congenital malfor-
mations1,2 and tumors of systemic organs including the ner-
vous tissue in rodents3. ENU mutagenesis has been used to 
create a large number of random point mutations in the ge-
nomic DNA of mice and zebrafish and is a powerful tool for 
creating animal models of disease4,5, such as morphological 
defects in the eyes6,7 and retinal degeneration in the prog-
eny of treated animals8–10. A single intraperitoneal injection 
of ENU also induces retinal and corneal damage in mature 
mice11,12; however, the mechanism of ENU-induced retinal 
damage in adult rodents is unclear.
Double-strand breaks (DSBs), the most deleterious 
kind of alteration to DNA, are produced by exogenous 
agents. One of the earliest events in the DNA damage re-
sponse is the Ser139 phosphorylation of histone H2A.X 
(γ-H2AX), which is a critical factor for cellular protection 
against DNA alkylating agents13–16. DNA alkylating agents 
also activate poly (ADP-ribose) polymerase (PARP)17. In 
several retinal damage models, such as NMDA-induced 
ganglion cell loss18, retinal ischemia/reperfusion injury19, 
retinal degeneration 1 (rd1) mice carrying the Pde 6b gene20, 
and N-methyl-N-nitrosourea (MNU)-induced photoreceptor 
apoptosis21, cell death is linked to PARP hyperactivation.
The purpose of this research is to evaluate the effect 
of ENU on the retinal cells of adult rats and to focus on the 
activation of γ-H2AX and PARP as DNA damage responses 
in the retina after ENU exposure.
Materials and Methods
Animals
Fifty-two male Lewis rats [LEW/CrlCrlj] obtained 
from Charles River Laboratories Japan (Osaka, Japan) were 
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used at 7 weeks of age. Rats were maintained in specific 
pathogen-free conditions and received free access to a com-
mercial diet (CMF 30Gy; Oriental Yeast, Chiba, Japan) and 
tap water. The animals were housed in plastic cages with 
paper-chip bedding (Paper Clean, SLC, Hamamatsu, Japan) 
in an air-conditioned room at 22 ± 2 °C and 60 ± 10% rela-
tive humidity with a 12-hr light/dark cycle. The illumination 
intensity was less than 60 lux in the cages. All procedures 
were in accordance with the guidelines for animal experi-
mentation at Kansai Medical University.
Chemical and dose formulation
ENU (N-Nitroso-N-ethylurea bulk package®; chemi-
cal formula, C3H7N3O2) was purchased from Sigma-Aldrich 
Japan (Tokyo, Japan) and kept at −80 °C in the dark. It was 
dissolved in physiologic saline just prior to use.
Experimental procedures
The experiments consisted of 2 independent studies, the 
purpose being to confirm the dose dependency of the retinal 
lesions in the 1st study and to confirm the sequential changes 
in the 2nd study. Sixteen rats received an intraperitoneal (ip) 
injection of ENU at a dose of 100, 200, 400 or 600 mg/kg 
(4 rats/group). Seven days after injection, rats were anesthe-
tized with isoflurane (Forane®, Abbott Japan, Tokyo, Japan) 
and  sacrificed  by  exsanguination  from  abdominal  aortic 
transection. In another experiment, 28 rats received a single 
ip injection of 400 mg/kg of ENU, and 4 randomly selected 
mice were sacrificed at 7 time points (3, 6, 12, 24 and 72 hr 
and 7 and 30 days) after treatment. In each experiment, the 
control groups consisted of 4 rats that were treated with ve-
hicle (physiological saline) only. All rats were observed daily 
for clinical signs of toxicity and were weighed at the time of 
ENU treatment and on the day of sacrifice. Both eyes were 
quickly removed at the time of sacrifice, and complete nec-
ropsies were conducted on all animals.
Tissue fixation and processing
One  eye  from  each  rat  was  fixed  overnight  in  10% 
neutral buffered formalin, and the other eye was fixed over-
night in methacarn (60% methanol, 30% chloroform and 
10% acetic acid). Subsequently, the eyes were embedded 
in paraffin, sectioned at a thickness of 4 μm, and stained 
with hematoxylin and eosin (HE). Ocular sections were cut 
along a line parallel to the optic axis and nerve (including 
the ora serrata). Histologic and morphometric evaluations 
were performed by a toxicologic pathologist certified by the 
Japanese Society of Toxicologic Pathology and the Inter-
national Academy of Toxicologic Pathology (K.Y.) and an 
ophthalmologist certified by the Japanese Ophthalmological 
Society (M.K.), according to the previously defined histo-
pathological terminology and diagnostic criteria11,22.
Morphometric analysis of retinal thickness, photore-
ceptor cell ratio and retinal damage ratio
HE-stained sections of the retina were scanned with a 
high-resolution digital slide scanner (NanoZoomer 2.2 Digi-
tal Pathology, Hamamatsu Photonics, Hamamatsu, Japan) to 
prepare digital images. The ndpi image files were opened 
in color mode with the NDP.view software (Hamamatsu 
Photonics). The total retinal thickness (from the internal 
limiting membrane to the pigment epithelium), inner reti-
nal thickness (from the internal limiting membrane to the 
outer plexiform layer) and outer retinal thickness (from the 
outer nuclear layer to the pigment epithelial cell layer) were 
individually measured from methacarn-fixed HE slides us-
ing NDP.view, as described in our previous reports11,22. The 
measurements were conducted at the central retina (approx-
imately 400 μm from the optic nerve) and peripheral retina 
(approximately 400 μm from both sides of the ciliary bod-
ies). To further evaluate the photoreceptor cell loss, the pho-
toreceptor ratio [(outer retinal thickness / total retinal thick-
ness) × 100] was calculated. To determine the area of retinal 
damage, the entire length of the retina and the length of the 
damaged area in HE preparations were measured. Damaged 
retina was designated as the presence of less than four rows 
of photoreceptor nuclei in the outer nuclear layer11,22, and the 
retinal damage ratio was calculated as: (length of damaged 
retina / whole retinal length) × 100.
TUNEL, phospho-histone H2A.X, and poly (ADP-
ribose) immunohistochemistry
Formalin-fixed eye sections at 6 time points (3, 6, 12, 24 
and 72 hr and 7 days) after treatment with 400 mg/kg ENU 
and at 7 days after vehicle treatment were used for the analy-
ses of cell death and DNA damage responses. Cell death was 
observed by terminal deoxynucleotidyl transferase (TdT)-
mediated dUTP digoxigenin nick end-labeling (TUNEL) us-
ing an in situ apoptosis detection kit (ApopTag; Millipore, 
Bellerica, MA, USA) according to previous reports11,22. 
Sequential sections were immunohistochemically stained 
with  anti-phospho-histone  H2A.X  (γ-H2AX)  monoclonal 
antibody (Ser139, 1:200 in dilution; Cell Signaling Technol-
ogy, Danvers, MA, USA), an immunomarker of the DNA 
damage response14,16,23 and anti-poly (ADP-ribose) (PAR) 
monoclonal antibody (10H, 1:200 in dilution; Enzo Life Sci-
ences International, Plymouth Meeting, PA, USA), an immu-
nomarker of the activation of poly (ADP-ribose) polymerase 
(PARP)19–21. PAR is synthesized after the activation of the 
nuclear DNA repair enzyme PARP. Antigen retrieval was 
necessary for γ-H2AX visualization and was conducted by 
pressure-cooker heating (Pascal, Dako, Carpinteria, CA, 
USA). Each primary antibody was reacted overnight under 
4 °C, and the antigen–antibody complexes were identified 
using an LSAB staining kit (Dako) according to the manu-
facturer’s instructions. The reaction products were visual-
ized with 3–3′-diaminobenzidine tetrahydrochloride.
Apoptotic and γ-H2AX cell ratio and PAR immunore-
activity
TUNEL-  and  γ-H2AX-stained  retinal  sections  were 
scanned with a high-resolution digital slide scanner to pre-
pare digital images. The images were captured at 40 × mag-
nification. The apoptotic cell ratio was calculated from TU-Yoshizawa, Sasaki, Uehara et al. 29
NEL-stained slides by determining the number of apoptotic 
nuclei of photoreceptor cells per microscopic field at the 
central retina and peripheral retina. The γ-H2AX-positive 
cells were counted in three microscopic fields per whole 
retina in a random fashion. The intensity grade of immune 
staining and expression for PAR in the retina was scored as 
negative, weak, moderate or strong.
Statistical analysis
All discrete values, expressed as means ± standard er-
ror (SE), were analyzed using the two-tailed independent 
Student’s t-test for unpaired samples after confirming the 
homogeneity of variances. The results presented below in-
clude comparisons between ENU-treated mice and vehicle-
treated mice. P values < 0.05 were considered to show sta-
tistical significance.
Results
General remarks
Mortality and body weight of ENU-treated rats were 
affected in a dose-dependent manner. Rats treated with 
600  mg/kg ENU exhibited decreased locomotor activity, 
and 2 of the 4 rats in this group died on day 7. There was a 
statistically significant decrease in the growth rates (weight 
gain) in all ENU-treated groups; the growth rates were 
61%, 92%, 115%, 120% and 127% in the 600, 400, 200 and 
100 mg/kg groups and the control group, respectively. The 
growth rate of the 400 mg/kg ENU-treated group decreased 
at 24 hr, peaked at day 7, and recovered at day 30 (data not 
shown).
Morphological and morphometric analysis of dose-
dependent retinal damage
The results of histological evaluation of the retinas of 
ENU- and vehicle-treated rats were compared 7 days after 
ENU treatment. The retinas of control rats contained more 
than 10 layers of photoreceptor nuclei in the central retina 
and more than 8 layers of cells in the peripheral retina (Fig. 
1). All rats treated with 600 mg/kg ENU had either no photo-
receptor cell nuclei or only a few rows of photoreceptor cell 
nuclei, such that the outer nuclear layer and photoreceptor 
layer almost disappeared in both the central and peripheral 
retina (Fig. 1). In 400 mg/kg ENU-treated rats, the central 
retina contained no photoreceptor cell nuclei or only a few 
rows of photoreceptor cell nuclei (Fig. 1), and the peripheral 
retina contained 5 or fewer rows of photoreceptor cell nuclei. 
The remaining photoreceptor nuclei were densely stained 
and contained clumped chromatin, suggesting that they were 
degenerating. The ENU-induced changes were restricted to 
photoreceptor cells; all other layers of the retina remained 
intact 7 days after ENU treatment. No other ENU-induced 
changes to the components of the eye (including the cornea) 
were observed. The retinas of all rats that received 200 mg/
kg ENU or less were histopathologically intact (Fig. 1).
Seven days after treatment with 600  mg/kg ENU, 
the total retinal thickness and outer retinal thickness were 
significantly decreased in both the central and peripheral 
retina, as compared with the control rats (Fig. 1), whereas 
400 mg/kg ENU caused a decrease in thickness in only the 
central retina with statistical significance (Fig. 2a). Changes 
in the inner retinal thickness were not observed in any of the 
ENU-treated groups (data not shown). To further evaluate 
the ENU-induced effects on retinal thickness, the photore-
ceptor cell ratio was calculated (Fig. 2a). The photoreceptor 
cell ratios at the central and peripheral retinas were 43% 
and 51% for control rats, but only 10% and 11% (P<0.01) in 
the 600 mg/kg ENU-treated rats and 9% (P<0.01) and 43% 
(not significant) in the 400 mg/kg ENU-treated rats. The 
photoreceptor cell ratios at the central and peripheral retina 
were not significantly different in rats treated with 200 mg/
kg ENU or less (46% and 50% in the 200 mg/kg group and 
46% and 50% in the 100  mg/kg group, respectively). To 
evaluate the degree of disease progression, the retinal dam-
age ratio was compared among the groups (Fig. 2b). The 
600 and 400 mg/kg ENU-induced damages were 100% and 
56%, respectively, while the damage was 0% in the 200 and 
100 mg/kg ENU-treated groups and vehicle-treated rats.
Morphological and morphometric analyses of sequen-
tial changes in retinal damage
Six hours after treatment with 400 mg/kg ENU, con-
densation and fragmentation of photoreceptor cell nuclei 
and vacuolar change in the photoreceptor layer occurred. 
The disruption and loss of the photoreceptor cell nuclei pro-
gressed at 24 hr, and widespread destruction and disappear-
ance of photoreceptor segments occurred at 72 hr (Fig. 3). 
A majority of the photoreceptor cell nuclei were lost in the 
central retina at day 7. As a result, the thickness of the total 
retina and the outer retina of ENU-treated rats decreased 
progressively, and cystoid degeneration was seen in the in-
ner retinal layer 30 days after treatment (Fig. 3). The pho-
toreceptor cell ratio at the central and peripheral retina was 
decreased significantly from 24 hr after ENU treatment; the 
photoreceptor cell ratios in the central and peripheral retina 
were decreased by 39% and 45% at 24 hr, 28% and 40% at 
72 hr, and 9% and 44% at day 7, respectively, and by 43% 
and 51% in control rats (Fig. 4). The retinal thickness on day 
30 was similar to the thickness 7 days after treatment. Dur-
ing the disease course, no inflammatory cell infiltration was 
seen in the retina.
Apoptotic cell ratio
In both the central and peripheral retina of the 400 mg/
kg ENU-treated rats, the TUNEL signal appeared selective-
ly in the photoreceptor cell nuclei, and some pyknotic photo-
receptor cell nuclei at 6 and 12 hr showed TUNEL positivity 
without obvious nuclear destruction. Many photoreceptor 
cell nuclei showed TUNEL positivity at 24 hr after treat-
ment (Fig. 5a). The sequential changes in the apoptotic cell 
ratio at 0, 3, 6, 12, 24 and 72 hr and 7 days were 0.6, 0.5, 2.8, 
13.4, 44.5, 19.8 and 1.4, respectively, in the central retina 
and 0.1, 0.1, 2.4, 15.5, 46.3, 21.1 and 0.6, respectively, in the 
peripheral retina (Fig. 5b).ENU-induced Retinal Damage in Rats 30
Fig. 1.  Retinal change in adult rats 7 days after a single ip injection of ENU. The outer nuclear layer and photoreceptor layer degenerated and/
or disappeared in both the peripheral and central retina of rats who received ≥ 400 mg/kg ENU. No change was seen in the retinas of 
rats treated with 200 or 100 mg/kg ENU. GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer 
plexiform layer; ONL, outer nuclear layer; PRL, photoreceptor layer; and PEL, pigment epithelial layer. HE staining, ×400.
Fig. 3.  Sequential retinal changes in adult rats after a single ip injection of 400 mg/kg ENU. Retinal cross sections were collected 3, 6, 12, 24 
and 72 hr and 7 and 30 days after ENU treatment. GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, 
outer plexiform layer; ONL, outer nuclear layer; PRL, photoreceptor layer; and PEL, pigment epithelial layer. HE staining, ×400.Yoshizawa, Sasaki, Uehara et al. 31
γ-H2AX cell ratio and PAR immunoreactivity
In the retinas of the 400 mg/kg ENU-treated rats, the 
γ-H2AX-positive cells were scattered almost evenly in the 
the whole retina. The γ-H2AX signal was localized to the 
the cell nuclei in the inner nuclear layer and was not accom-
panied by any obvious morphological nuclear changes. The 
signal appeared 24 hr after ENU treatment, and the index 
peaked 72 hr after ENU treatment (Fig. 6a). The sequential 
changes in the γ-H2AX cell ratio were 0, 0, 0, 0, 3, 16.3 and 
1.8 at 0, 3, 6, 12, 24 and 72 hr and 7 days (Fig. 6b). PAR 
signals were not detected in the control retina. At 12 hr after 
ENU treatment, the signals were localized to the photore-
ceptor cell nuclei at the central and peripheral retina. The 
expression peaked at 24 hr after treatment, and the signals 
disappeared 7 days after treatment.
Discussion
The present study provides new evidence of ENU-in-
duced retinal changes. Retinal degeneration characterized 
by the loss of the outer nuclear layer and photoreceptor layer 
in the central and peripheral retina was detected in ENU-
treated adult rats after a single ip injection of ≥ 400 mg/kg 
ENU. The outer nuclear layer and photoreceptor layer of 
ENU-treated rats decreased progressively due to photore-
ceptor cell apoptosis, which was characterized by the pres-
Fig. 2.  Photoreceptor cell ratios in the central retina and peripheral 
retina 7 days after a single ip injection of ENU into adult rats 
(a). Rats treated with 600 and 400 mg/kg ENU had a statisti-
cally significant decrease in photoreceptor ratio at the central 
and/or peripheral retina, as compared with saline-treated con-
trols. The index was calculated as [(outer retinal thickness/
total retinal thickness) × 100]. Retinal damage ratios in ENU-
treated adult rats (b). The index was evaluated as [(length of 
retina composed of less than four rows of photoreceptor cells/
whole retinal length) × 100]. The mean ± SE of the four rats in 
each treatment group is shown. **: P<0.01.
Fig. 4.  Sequential changes in the photoreceptor cell ratios of the cen-
tral and peripheral retina after a single ip injection of 400 mg/
kg ENU into adult rats. The index was calculated as [(outer 
retinal thickness/total retinal thickness) × 100]. The mean ± 
SE of the four rats in each treatment group is shown. * and **: 
P<0.05 and P<0.01, respectively.ENU-induced Retinal Damage in Rats 32
ence of TUNEL-positive nuclei restricted to photoreceptor 
cells. Photoreceptor cell apoptosis was evident at 6 hr and 
peaked at 72 hr after ENU treatment, followed by extensive 
photoreceptor cell loss at day 7. A morphometric analysis 
showed that photoreceptor cell damage occurred similarly 
in both the central and peripheral retina in rats treated with 
600  mg/kg ENU, while 400  mg/kg ENU caused loss of 
outer retinal layers located mainly in the central retina at 
7 days after exposure. Therefore, the central retina may be 
more sensitive to ENU-induced damage. ENU is a stem-cell 
mutagen that also affects hematopoietic stem cells and im-
mune cells, and animals are highly susceptible to infection 
after injection of ENU24. In the present study, the deaths in 
the 600 mg/kg dose group may have been caused by hema-
topoietic toxicity and immunotoxicity.
Fig. 5. TUNEL-positive photoreceptor cells in the outer nuclear 
layer 24 hr after a single ip injection of 400 mg/kg ENU into 
adult rats (a). The signals are seen in many photoreceptor 
cell nuclei, although no or few signals are seen in the con-
trol retina (b). GCL, ganglion cell layer; IPL, inner plexiform 
layer; INL, inner nuclear layer; OPL, outer plexiform layer; 
ONL, outer nuclear layer; PRL, photoreceptor layer; and PEL, 
pigment epithelial layer. TUNEL staining, ×400. Sequential 
changes in the apoptotic cells per field were evaluated in the 
central and peripheral retina, respectively (c). Mean ± SE; 
each bar represents four rats. * and **: P<0.05 and P<0.01, 
respectively.
Fig. 6.  γ-H2AX-positive cells per field in the inner nuclear layer 72 
hr after a single ip injection of 400 mg/kg ENU into adult rats 
(a). The signals are seen in several inner retinal cell nuclei, 
although no signals are seen in the control retina (b). GCL, 
ganglion cell layer; IPL, inner plexiform layer; INL, inner 
nuclear layer; OPL, outer plexiform layer; and ONL, outer 
nuclear layer. γ-H2AX immunohistochemical staining, ×800. 
Sequential changes in the γ-H2AX-positive cells of the inner 
retina (c). Mean ± SE, each bar represents four rats. * and **: 
P<0.05 and P<0.01, respectively.
Fig. 7.  Sequential PAR expression in the retina after a single ip injec-
tion of 400 mg/kg ENU into adult rats. PAR immunoreactivi-
ties located in the photoreceptor cell nuclei were seen at 12 hr 
and peaked at 24 hr after ENU treatment. INL, inner nuclear 
layer; OPL, outer plexiform layer; ONL, outer nuclear layer; 
and PRL, photoreceptor layer. PAR immunohistochemical 
staining, ×600.Yoshizawa, Sasaki, Uehara et al. 33
ENU is the most potent mutagen in rodents4,5,25, and 
it can be used to generate point mutations throughout the 
mouse genome25. Various mouse models for human diseases 
have been generated by a systematic, large-scale, genome-
wide phenotyping screen in the last decade5. The eyes of 
ENU-treated animals exhibit morphological defects, such 
as lens opacity, microphthalmia, corneal adhesion, corneal 
opacity, pink eye, iris anomalies, coloboma, and preretinal 
blood vessels5–7. The progeny of ENU-treated animals ex-
hibit retinal degeneration8–10. In addition, a single ip injec-
tion of 100 mg/kg ENU on day 14 of gestation or of 200 mg/
kg ENU on day 3 after birth induces rosette-like structures 
(dysplasia) in the retinas of fetal and neonatal rats, respec-
tively2,26. Although ENU has been used as a carcinogen and 
mutagen in many animal toxicity and carcinogenesis stud-
ies, there has been only one report concerning the effect of 
ENU on the retinas of adult mice11, and this previous study 
was conducted by our group. To the best of our knowledge, 
the present study is the first report on ENU-induced retinal 
injury in adult rats.
Inherited night blindness is a fairly widespread dis-
ease in humans, and it affects approximately one in 5,000 
individuals worldwide. A common form of inherited blind-
ness is retinitis pigmentosa, which is a degenerative pig-
mentary retinopathy that is noninflammatory, bilateral and 
progressive27,28. Animal models of retinal degeneration are 
important for elucidating the mechanism of human retinitis 
pigmentosa28–30 and exploring potential treatments28,31. The 
retinal degeneration (photoreceptor cells loss) induced by 
N-methyl-N-nitrosourea (MNU), which is an ENU-related 
compound25, has been well studied as one of the rodent 
models of retinitis pigmentosa22,31. MNU causes DNA ad-
duct formation in photoreceptor nuclei, followed by apop-
tosis via the downregulation of Bcl-2, upregulation of Bax 
and activation of the PARP and caspase families in rats. In 
contrast, few studies have focused on ENU-induced retinal 
damage in adult rodents.
In the present study, ENU induced an increased number 
of TUNEL-positive photoreceptor cells in parallel with the 
expression of PAR signals. The PAR signals were expressed 
selectively in the photoreceptor cell nuclei. The signals ap-
peared 12 hr after ENU treatment, and the immunoreactiv-
ity peaked 72 hr after ENU treatment. PAR is synthesized 
after activation of the nuclear DNA repair enzyme PARP. 
However, under conditions of severe DNA damage, exces-
sive activation of PARP results in depletion of the cellular 
pool of nicotinamide adenine dinucleotide and ATP, which 
is followed by cell death21.
γ-H2AX  is  a  critical  factor  for  cellular  protection 
against DNA alkylating agents15, and it can mediate DNA 
repair13,14,16,32. Methylating agents such as MNU can cause 
cell-cycle arrest, γ-H2AX expression and cell death, either 
via caspase-dependent apoptosis or via a PARP-dependent 
form of apoptosis33. Two forms of γ-H2AX expression have 
been elucidated. The transient form of γ-H2AX expression 
is associated with the repair and removal of double-strand 
breaks from the nucleus. The other form of γ-H2AX expres-
sion involves the formation of foci by more persistent dou-
ble-strand breaks that tend to accumulate and remain unre-
paired in cells14. In ENU-induced retinal damage, γ-H2AX 
signals appeared in the inner retinal cells 24 hr after ENU 
exposure, peaked at 72 hr and then disappeared. No cell 
death in the inner retina could be seen at any point, sug-
gesting that the cells recovered from the DNA damage. The 
identity of the γ-H2AX-positive cells located in the inner 
nuclear layer (bipolar cells, horizontal cells, amacrine cells 
or Muller cells) was not determined. Moreover, γ-H2AX 
expression was not detected in the outer retina where cell 
death occurred. Further studies concerning the DNA dam-
age cascade and cell type in the inner retina are necessary 
to understand the detailed pathogenesis of ENU-induced 
γ-H2AX expression in the inner retina.
Hypofluorescence in indocyanine green angiography is 
seen in the chorioretinal atrophic area in MNU-treated reti-
nal degeneration34. Also, the vascular sequential changes in 
MNU-treated retinal degeneration have been reported35; the 
numbers of acellular capillaries, ghost cells and vessels ex-
hibiting narrowing in trypsin-digested retinal vessels were 
increased after MNU exposure. These data may suggest 
ischemic or hypoxic conditions in the retina after MNU ex-
posure. Under ischemic or hypoxic conditions, target cells 
express γ-H2AX as a DNA damage response and progress 
through the DNA repair pathway36. In our study, although 
angiographic analysis was not conducted, the inner retina 
may have been under ischemic or hypoxic conditions after 
ENU exposure, and this may have been followed by progres-
sion through the DNA repair pathway. Therefore, γ-H2AX 
expression in the inner retina may be a secondary effect due 
to the ischemic or hypoxic conditions that developed after 
the outer retinal damage was induced by ENU exposure.
The survival of neurons from the potentially damag-
ing events caused by unregulated cell-protective signaling 
and DNA repair is a complex process that requires multiple 
steps and enzymes. Exposure to ENU causes the forma-
tion of DNA adducts, such as O6-alkylguanine, in the target 
cells37–39. The adduct is removed by repair enzymes such as 
O6-methylguanine-DNA methyltransferase (MGMT)38,40. 
Additionally, DNA polymerase β is essential for the repair 
of DNA lesions damaged by exogenous genotoxin41. DNA 
polymerase β is responsible for 99% of the polymerase ac-
tivity in neurons42 and is upregulated during light-induced 
retinal degeneration43. Further studies of the DNA repair 
cascade in the inner retina are necessary to understand the 
detailed pathogenesis of ENU-induced retinal degeneration.
In conclusion, retinal degeneration occurred in adult 
rats after a single intraperitoneal injection of 400  mg/
kg ENU. ENU-induced retinal degeneration was related 
to photoreceptor cell apoptosis via PARP activation. The 
γ-H2AX signals were expressed only in inner retinal cells 
and disappeared promptly, suggesting that the inner retinal 
cells recovered from DNA damage. Investigations of the de-
tailed mechanisms of ENU-induced retinal degeneration are 
necessary for a better understanding of the pathogenesis of 
chemical-induced retinal degeneration.ENU-induced Retinal Damage in Rats 34
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